Bluepharma was recognised as a national example of innovation and value creation with the award of the “COTEC Innovative Status 2025”, granted by COTEC Portugal – the business association dedicated to promoting innovation and technological cooperation in Portugal.
This distinction highlights solid financial soundness, investment in innovation capital, and quality and management culture – essential ingredients for increasing competitive potential and economic results.
For Bluepharma’s President, Paulo Barradas Rebelo, this distinction represents “an important recognition of the rigorous work carried out over 24 years” and reinforces “the pride and trust placed in us.”
By being distinguished with this status, Bluepharma joins a network of innovative companies, gaining access to new partnerships, fostering its continuous development and contributing significantly to the national economy.
